$1,211.39 travel Payment -- Takeda Pharmaceuticals to Dr. Susan Taylor

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Takeda Pharmaceuticals made a $1.2K travel payment to Susan Taylor, a Rare Disease specialist in Detroit, MI. The payment was associated with Dupixent. The payment of $1211.39 to Dr. Susan Taylor covers travel and lodging expenses. This payment was made by Takeda Pharmaceuticals on February 26, 2026. The payment is associated with Dupixent, a drug used in Rare Disease treatment.

Patient Guidance: What This Payment Means for You

This payment covers travel and lodging, which may be related to educational events or conferences concerning medical treatments. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in the pharmaceutical industry, particularly for specialists attending educational events related to specific drugs or conditions.

Regulatory Context: Sunshine Act Requirements

Payments to physicians for travel and lodging must be reported under the Sunshine Act to ensure transparency in industry-physician relationships.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• travel-and-lodging
• rare-disease
• takeda-pharmaceuticals
• physician-payments
• dupixent

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $1.2K payment for?

This was a travel payment of $1.2K from Takeda Pharmaceuticals to Susan Taylor, categorized as "Travel and Lodging". It was associated with Dupixent. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Susan Taylor accept pharmaceutical money?

Yes, Susan Taylor received this $1.2K payment from Takeda Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Susan Taylor's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $1.2K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Rare Disease?

To compare this payment against Rare Disease averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Rare Disease physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Susan Taylor's relationship with Takeda Pharmaceuticals?

The payment amount is specific and itemized as travel and lodging. This $1.2K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Rare Disease?

The payment date is in the future, suggesting a planned event or conference.

What should patients do after learning about this payment?

This payment covers travel and lodging, which may be related to educational events or conferences concerning medical treatments.

What else should I know about this travel payment?

Dr. Taylor's specialty is Rare Disease, indicating a focus on a niche medical area.

Related Reports

• View Dr. Susan Taylor's full payment report
• Takeda Pharmaceuticals full spending report
• Browse all Rare Disease payments
• Browse all payments in Michigan
• Search for other payments